Literature DB >> 2709373

Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.

K A Jacobson1, S Barone, U Kammula, G L Stiles.   

Abstract

Functionalized congeners derived from 1,3-dipropyl-8-phenylxanthine and from N6-phenyladenosine were derivatized to contain electrophilic groups (isothiocyanate, N-hydroxysuccinimide ester, maleimide, sulfonyl chloride, or alpha-haloacyl group) capable of reaction with nucleophiles on biopolymers. The goal was to inhibit chemically the A1 adenosine receptor by using reactive agonist and antagonist ligands. Some of the electrophilic derivatives were synthesized through acylation of amine-functionalized congeners using hetero- or homobifunctional reagents available for protein cross-linking. The affinity for A1 adenosine receptors was evaluated in competitive binding assays by using rat and bovine brain membranes. Several xanthine and adenosine thiourea derivatives prepared from 1,3- and 1,4-phenylene diisothiocyanate (DITC) were potent irreversible inhibitors of adenosine receptors. Derivatives of m-DITC, at concentrations between 10 and 500 nM, irreversibly eliminated binding at 90% of the A1-receptor sites. Receptor affinity of both xanthine and adenosine derivatives containing distal phenylthiourea substituents was diminished by electron-donating groups on the ring.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2709373      PMCID: PMC3442263          DOI: 10.1021/jm00125a019

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  36 in total

1.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

2.  cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor.

Authors:  B K Kobilka; R A Dixon; T Frielle; H G Dohlman; M A Bolanowski; I S Sigal; T L Yang-Feng; U Francke; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

3.  Identification of a Mr 58 000 glycoprotein subunit of the opiate receptor.

Authors:  W A Klee; W F Simonds; F W Sweat; T R Burke; A E Jacobson; K C Rice
Journal:  FEBS Lett       Date:  1982-12-13       Impact factor: 4.124

4.  A specific acylating agent for the [3H]phencyclidine receptors in rat brain.

Authors:  M F Rafferty; M Mattson; A E Jacobson; K C Rice
Journal:  FEBS Lett       Date:  1985-02-25       Impact factor: 4.124

5.  Affinity labels for beta-adrenoceptors: preparation and properties of alkylating beta-blockers derived from indole.

Authors:  J Pitha; W Buchowiecki; J Milecki; J W Kusiak
Journal:  J Med Chem       Date:  1987-04       Impact factor: 7.446

6.  Kinetics of cholesterol and phospholipid exchange from membranes containing cross-linked proteins or cross-linked phosphatidylethanolamines.

Authors:  R Bittman; S Clejan; B P Robinson; N M Witzke
Journal:  Biochemistry       Date:  1985-03-12       Impact factor: 3.162

7.  A specific alkylating ligand for phencyclidine (PCP) receptors antagonizes PCP behavioral effects.

Authors:  P C Contreras; M F Rafferty; R A Lessor; K C Rice; A E Jacobson; T L O'Donohue
Journal:  Eur J Pharmacol       Date:  1985-05-20       Impact factor: 4.432

8.  Antagonism of phencyclidine action by metaphit in rat cerebellar Purkinje neurons: an electrophysiological study.

Authors:  Y Wang; M Palmer; R Freedman; B Hoffer; M V Mattson; R A Lessor; K C Rice; A E Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

9.  Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.

Authors:  D Ukena; K A Jacobson; W L Padgett; C Ayala; M T Shamim; K L Kirk; R O Olsson; J W Daly
Journal:  FEBS Lett       Date:  1986-12-01       Impact factor: 4.124

10.  Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors.

Authors:  K A Jacobson; K L Kirk; W L Padgett; J W Daly
Journal:  J Med Chem       Date:  1985-09       Impact factor: 7.446

View more
  23 in total

Review 1.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

2.  [(3)H]XAC (xanthine amine congener) is a radioligand for A(2)-adenosine receptors in rabbit striatum.

Authors:  X D Ji; G L Stiles; K A Jacobson
Journal:  Neurochem Int       Date:  1991       Impact factor: 3.921

Review 3.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

4.  Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

Authors:  K A Jacobson; G L Stiles; X D Ji
Journal:  Mol Pharmacol       Date:  1992-07       Impact factor: 4.436

5.  Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node.

Authors:  D Dennis; K Jacobson; L Belardinelli
Journal:  Am J Physiol       Date:  1992-03

6.  Differential A(1)-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT(1) MF-2 cells.

Authors:  S P Baker; P J Scammells; L Belardinelli
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

7.  Persistent activation by and receptor reserve for an irreversible A1-adenosine receptor agonist in DDT1 MF-2 cells and in guinea pig heart.

Authors:  J Zhang; L Belardinelli; K A Jacobson; D H Otero; S P Baker
Journal:  Mol Pharmacol       Date:  1997-09       Impact factor: 4.436

8.  Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.

Authors:  K A Jacobson; C Gallo-Rodriguez; N Melman; B Fischer; M Maillard; A van Bergen; P J van Galen; Y Karton
Journal:  J Med Chem       Date:  1993-05-14       Impact factor: 7.446

9.  An irreversible A1-selective adenosine agonist preconditions rabbit heart.

Authors:  G S Liu; K A Jacobson; J M Downey
Journal:  Can J Cardiol       Date:  1996-05       Impact factor: 5.223

Review 10.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).

Authors:  Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-04-30       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.